|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Mortgage loan receivables held for investment, net, at amortized cost: | ||||||||||||||||||||
| Mortgage loans receivable | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Mortgage loan receivables held for sale | ||||||||||||||||||||
| Securities | ||||||||||||||||||||
| Real estate and related lease intangibles, net | ||||||||||||||||||||
| Real estate held for sale, net | ||||||||||||||||||||
| Investments in and advances to unconsolidated ventures | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Debt obligations, net | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies (refer to Note 16) | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Class A common stock, par value $0.001 per share, 600,000,000 shares authorized; 130,790,591 and 130,790,591 shares issued and 125,992,003 and 127,233,559 shares outstanding as of September 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, 4,798,588 and 3,557,032 shares, at cost | ||||||||||||||||||||
| Retained earnings (dividends in excess of earnings) | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests in consolidated ventures | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
